<DOC>
	<DOCNO>NCT01623180</DOCNO>
	<brief_summary>The purpose study demonstrate BioFreedom™ Drug Coated Stent non-inferior bare metal stent one year measure composite safety endpoint cardiovascular death , myocardial infarction definite/probable stent thrombosis , efficacy superior bare metal stent measure clinically drive TLR one year .</brief_summary>
	<brief_title>A Randomized Clinical Evaluation BioFreedom™ Stent</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Coronary Restenosis</mesh_term>
	<criteria>Any indication PCIS patient deem high risk bleed candidate 1 month DAPT . This include candidate stable angina , silent ischemia , ACS ( STEMI nonSTEMI ) , nonnative lesion instent restenosis . Patients must provide write informed consent . 1 . Pregnancy 2 . Patients expect comply 1 month DAPT 3 . Patients require plan stag PCI procedure one week index procedure 4 . Procedure plan require nonstudy stent , stand alone POBA standalone atherectomy 5 . Active bleeding time inclusion 6 . Reference vessel diameter &lt; 2.25 &gt; 4.0mm 7 . Cardiogenic shock 8 . Compliance longterm single antiplatelet therapy unlikely 9 . A known hypersensitivity contraindication aspirin , clopidogrel ( prasugrel , ticagrelor applicable ) , stainless steel , Biolimus A9 sensitivity contrast medium , adequately premedicated . 10 . Participation another clinical trial ( 12 month index procedure ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>DES</keyword>
	<keyword>coronary stent</keyword>
	<keyword>bare metal stent</keyword>
	<keyword>high bleeding</keyword>
	<keyword>MI</keyword>
	<keyword>angina</keyword>
</DOC>